Internal Medicine, Endocrinology, Diabetes, & Metabolism · Orange City, FL
NPI
1972766954
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2885 Wellness Ave
Orange City, FL, 32763
Phone (386) 917-7627
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
3,499 services
Medicare patients, 2024
416
Average age 73
Drug cost, 2024
$1.6M
5,459 prescriptions
Company payments, 2025
$30.17
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charlene T Robertson was code J0897 (injection, denosumab, 1 mg), 2,700 times for 26 patients. In total Charlene T Robertson billed 3,499 services in 9 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,700 | 26 | $20.61 | $56K |
| 99214 Office E&M - Established | Office | 670 | 389 | $90.76 | $61K |
| 96372 Injection Administration | Office | 57 | 34 | $11.28 | $643 |
| 99204 Office E&M - New | Office | 48 | 48 | $129.49 | $6,215 |
By year: 2022 $85K for 2,170 services; 2023 $99K for 2,795 services; 2024 $124K for 3,499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charlene T Robertson prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,318 prescriptions and refills. In total Charlene T Robertson wrote 5,459 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,318 | 3,347 | 350 | $12K |
| Synthroid Levothyroxine Sodium | 338 | 840 | 88 | $33K |
| Metformin Hcl Er Metformin Hcl | 326 | 908 | 116 | $3,132 |
| Euthyrox Levothyroxine Sodium | 303 | 667 | 66 | $2,071 |
| Liothyronine Sodium Generic | 261 | 701 | 70 | $9,663 |
| Metformin Hcl Generic | 196 | 577 | 71 | $1,333 |
| Ozempic Semaglutide | 180 | 344 | 62 | $329K |
| Jardiance Empagliflozin | 173 | 362 | 55 | $205K |
| Januvia Sitagliptin Phosphate | 122 | 246 | 44 | $131K |
| Alendronate Sodium Generic | 119 | 284 | 36 | $1,180 |
| Methimazole Generic | 113 | 281 | 39 | $1,129 |
| Mounjaro Tirzepatide | 97 | 149 | 27 | $157K |
| Rosuvastatin Calcium Generic | 93 | 270 | 35 | $861 |
| Prolia Denosumab | 87 | 513 | 55 | $150K |
| Cinacalcet Hcl Generic | 83 | 197 | 21 | $10K |
Brand drugs: 2,750 claims; generic drugs: 2,625 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charlene T Robertson $30.17 ($30.17 in general payments such as food, travel and fees) from 2 companies. The largest payer was Insulet Corporation with $16.09.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.